UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prodrugs of New Psychoactive Substances (NPS): A New Challenge

Journal of forensic sciences, 2020-05, Vol.65 (3), p.913-920

2020

Volltextzugriff (PDF)

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

Neuropsychopharmacology (New York, N.Y.), 2012-04, Vol.37 (5), p.1192-1203

2012

Volltextzugriff (PDF)

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Neuropsychopharmacology (New York, N.Y.), 2013-03, Vol.38 (4), p.552-562

2013

Volltextzugriff (PDF)

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers

European neuropsychopharmacology, 2021-03, Vol.44, p.92-104

2021

Volltextzugriff (PDF)

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues

PloS one, 2016-06, Vol.11 (6), p.e0157021

2016

Volltextzugriff (PDF)

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Psychopharmacology, 2019-02, Vol.236 (2), p.799-808

2019

Volltextzugriff (PDF)

Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter

International journal of molecular sciences, 2021-11, Vol.22 (23), p.12995

2021

Volltextzugriff (PDF)

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Drug testing and analysis, 2018-02, Vol.10 (2), p.310-322

2018

Volltextzugriff (PDF)

Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration

Drug testing and analysis, 2020-08, Vol.12 (8), p.1144-1153

2020

Volltextzugriff (PDF)

In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

Metabolites, 2024-05, Vol.14 (5), p.270

2024

Volltextzugriff (PDF)

Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones

Drug testing and analysis, 2011-09, Vol.3 (9), p.569-575

2011

Volltextzugriff (PDF)

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Neuropharmacology, 2020-05, Vol.167, p.107933-107933, Article 107933

2020

Volltextzugriff (PDF)

Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry

Analytical chemistry (Washington), 2013-09, Vol.85 (18), p.8535-8542

2013

Volltextzugriff (PDF)

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Current neuropharmacology, 2017-07, Vol.15 (5), p.692-712

2017

Volltextzugriff (PDF)

Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS

Current pharmaceutical biotechnology, 2018, Vol.19 (2), p.144-162

2018

Volltextzugriff (PDF)

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

1st ed. 2018., 2019

Volltextzugriff (PDF)

In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity

Metabolites, 2021-08, Vol.11 (8), p.509

2021

Volltextzugriff (PDF)

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

New Psychoactive Substances, 2018, Vol.252, p.165-190

2018

Volltextzugriff (PDF)

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

New Psychoactive Substances, 2018-01, p.305-352

2018

Volltextzugriff (PDF)

The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis

Drug testing and analysis, 2016-08, Vol.8 (8), p.875-879

2016

Volltextzugriff (PDF)

Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N‐methoxy positional isomer, N‐methoxymephedrone

Drug testing and analysis, 2017-03, Vol.9 (3), p.358-368

2017

Volltextzugriff (PDF)

Fatal Poisonings Associated with New Psychoactive Substances

New Psychoactive Substances, 2018-01, Vol.252, p.495-541

2018

Volltextzugriff (PDF)

Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures

New Psychoactive Substances, 2018-01, Vol.252, p.3-49

2018

Volltextzugriff (PDF)

Potential antimalarial derivatives from astraodorol

Archives of Pharmacal Research, 2014, 37(12), , pp.1538-1545

2014

Volltextzugriff (PDF)

Addressing the challenges in forensic drug chemistry II

Drug testing and analysis, 2022-03, Vol.14 (3), p.400-403

2022

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(284)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prodrugs of New Psychoactive Substances (NPS): A New Challenge

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration

In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS

New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology

In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis

Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N‐methoxy positional isomer, N‐methoxymephedrone

Fatal Poisonings Associated with New Psychoactive Substances

Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures

Potential antimalarial derivatives from astraodorol

Addressing the challenges in forensic drug chemistry II

Suchergebnisse filtern